Loading clinical trials...
Loading clinical trials...
A Phase 1b/2 Randomized Study of AVB-S6-500 Plus Nab-paclitaxel and Gemcitabine in Patients With Locally Advanced or Metastatic Pancreatic Adenocarcinoma
Conditions
Interventions
batiraxcept
Nab paclitaxel
+1 more
Locations
17
United States
UCLA Health
Santa Monica, California, United States
Boca Raton Regional Hospital / Lynn Cancer Institute
Boca Raton, Florida, United States
Moffit Cancer Center
Tampa, Florida, United States
University of Massachusetts Memorial Medical Center
Worcester, Massachusetts, United States
Michigan Medicine - University of Michigan
Ann Arbor, Michigan, United States
Roswell Park Comprehensive Cancer Center
Buffalo, New York, United States
Start Date
July 28, 2021
Primary Completion Date
August 14, 2023
Completion Date
August 14, 2023
Last Updated
October 30, 2023
NCT06423326
NCT04389632
NCT04895709
NCT05825066
NCT07409272
NCT04605913
Lead Sponsor
Aravive, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions